Literature DB >> 16927309

Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation.

Jong-Sup Bae1, Soraya Gutierrez, Radhika Narla, Jitesh Pratap, Rajitha Devados, Andre J van Wijnen, Janet L Stein, Gary S Stein, Jane B Lian, Amjad Javed.   

Abstract

The Runx2/Cbfa1 transcription factor is a scaffolding protein that promotes osteoblast differentiation; however, the specific Runx2-functional domains required for induction of the osteogenic lineage remain to be identified. We approached this question using a TERT-immortalized cell line derived from calvaria of Runx2-null mice by reconstituting the osteogenic activity with wild-type and deletion mutants of Runx2. The presence or absence of osteogenic media (beta-glycerol phosphate and ascorbic acid) and/or with BMP2 did not stimulate osteoblastic gene expression in the Runx2-null cells. However, cells infected with wild-type Runx2 adenovirus showed a robust temporal increase in the expression of osteoblast marker genes and were competent to respond to BMP2. Early markers (i.e., collagen type-1, alkaline phosphatase) were induced (four- to eightfold) at Days 4 and 8 of culture. Genes representing mature osteoblasts (e.g., Runx2, osteopontin, bone sialoprotein, osteocalcin) were temporally expressed and induced from 18- to 36-fold at Days 8 and 12. Interestingly, TGFbeta and Vitamin D-mediated transcription of osteoblast genes (except for osteopontin) required the presence of Runx2. Runx2 lacking the C-terminal 96 amino acids (Runx2 Delta432) showed a pattern of gene expression similar to wild-type protein, demonstrating the Groucho interaction and part of the activation domain are dispensable for Runx2 osteogenic activity. Upon further deletion of the Runx2 C-terminus containing the nuclear matrix targeting signal and Smad-interacting domain (Delta391), we find none of the osteoblast markers are expressed. Therefore, the Runx2 391-432 domain is essential for execution of the BMP2 osteogenic signal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16927309     DOI: 10.1002/jcb.21039

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  32 in total

1.  Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification.

Authors:  Yong Sun; Chang Hyun Byon; Kaiyu Yuan; Jianfeng Chen; Xia Mao; Jack M Heath; Amjad Javed; Kui Zhang; Peter G Anderson; Yabing Chen
Journal:  Circ Res       Date:  2012-07-06       Impact factor: 17.367

2.  Co-stimulation of the bone-related Runx2 P1 promoter in mesenchymal cells by SP1 and ETS transcription factors at polymorphic purine-rich DNA sequences (Y-repeats).

Authors:  Ying Zhang; Mohammad Q Hassan; Rong-Lin Xie; John R Hawse; Thomas C Spelsberg; Martin Montecino; Janet L Stein; Jane B Lian; Andre J van Wijnen; Gary S Stein
Journal:  J Biol Chem       Date:  2008-11-18       Impact factor: 5.157

3.  Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.

Authors:  Héctor F Araya; Hugo Sepulveda; Carlos O Lizama; Oscar A Vega; Sofia Jerez; Pedro F Briceño; Roman Thaler; Scott M Riester; Marcelo Antonelli; Flavio Salazar-Onfray; Juan Pablo Rodríguez; Ricardo D Moreno; Martin Montecino; Martine Charbonneau; Claire M Dubois; Gary S Stein; Andre J van Wijnen; Mario A Galindo
Journal:  J Cell Biochem       Date:  2018-06-19       Impact factor: 4.429

4.  1alpha,25-dihydroxy vitamin D(3) induces nuclear matrix association of the 1alpha,25-dihydroxy vitamin D(3) receptor in osteoblasts independently of its ability to bind DNA.

Authors:  Gloria Arriagada; Roberto Paredes; Andre J van Wijnen; Jane B Lian; Brigitte van Zundert; Gary S Stein; Janet L Stein; Martin Montecino
Journal:  J Cell Physiol       Date:  2010-02       Impact factor: 6.384

5.  Runx2 protein expression utilizes the Runx2 P1 promoter to establish osteoprogenitor cell number for normal bone formation.

Authors:  Julie C Liu; Christopher J Lengner; Tripti Gaur; Yang Lou; Sadiq Hussain; Marci D Jones; Brent Borodic; Jennifer L Colby; Heather A Steinman; Andre J van Wijnen; Janet L Stein; Stephen N Jones; Gary S Stein; Jane B Lian
Journal:  J Biol Chem       Date:  2011-06-15       Impact factor: 5.157

6.  Haploinsufficiency of Runx2 results in bone formation decrease and different BSP expression pattern changes in two transgenic mouse models.

Authors:  Qisheng Tu; Jin Zhang; Jeff Paz; Katherine Wade; Pishan Yang; Jake Chen
Journal:  J Cell Physiol       Date:  2008-10       Impact factor: 6.384

Review 7.  Regulation of gene expression in osteoblasts.

Authors:  Eric D Jensen; Rajaram Gopalakrishnan; Jennifer J Westendorf
Journal:  Biofactors       Date:  2010 Jan-Feb       Impact factor: 6.113

8.  Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal.

Authors:  Amjad Javed; Jong-Sup Bae; Faiza Afzal; Soraya Gutierrez; Jitesh Pratap; Sayyed K Zaidi; Yang Lou; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  J Biol Chem       Date:  2008-01-18       Impact factor: 5.157

9.  Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.

Authors:  Jitesh Pratap; John J Wixted; Tripti Gaur; Sayyed K Zaidi; Jason Dobson; Karthiga Devi Gokul; Sadiq Hussain; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

10.  FGF2 stimulation of the pyrophosphate-generating enzyme, PC-1, in pre-osteoblast cells is mediated by RUNX2.

Authors:  Nan E Hatch; Yan Li; Renny T Franceschi
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.